Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SV40-TRANSFORMED CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 350 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fisher, DE
      The p53 tumor suppressor: Critical regulator of life & death in cancer

      APOPTOSIS
    2. Lutzker, SG; Lattime, EC
      Use of dendritic cells to immunize against cancers overexpressing p53

      CLINICAL CANCER RESEARCH
    3. Ali, SH; DeCaprio, JA
      Cellular transformation by SV40 large T antigen: interaction with host proteins

      SEMINARS IN CANCER BIOLOGY
    4. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    5. Giannakakou, P; Robey, R; Fojo, T; Blagosklonny, MV
      Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity

      ONCOGENE
    6. Huo, TI; Wang, XW; Forgues, M; Wu, CG; Spillare, EA; Giannini, C; Brechot, C; Harris, CC
      Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis

      ONCOGENE
    7. Weiss, RH; Howard, LL
      p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque

      CELLULAR SIGNALLING
    8. Robles, AI; Harris, CC
      p53-mediated apoptosis and genomic instability diseases

      ACTA ONCOLOGICA
    9. Utermohlen, O; Schulze-Garg, C; Warnecke, G; Gugel, R; Lohler, J; Deppert, W
      Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells

      JOURNAL OF VIROLOGY
    10. Nakamura, H; Li, M; Zarycki, J; Jung, JU
      Inhibition of p53 tumor suppressor by viral interferon regulatory factor

      JOURNAL OF VIROLOGY
    11. Collins, LL; Lin, DL; Mu, XM; Chang, CS
      Feedback regulation between orphan nuclear receptor TR2 and human papilloma virus type 16

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Strano, S; Rossi, M; Fontemaggi, G; Munarriz, E; Soddu, S; Sacchi, A; Blandino, G
      From p63 to p53 across p73

      FEBS LETTERS
    13. Guiducci, C; Anglana, M; Wang, A; Bacchetti, S
      Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells

      EXPERIMENTAL CELL RESEARCH
    14. Asamoto, M; Hokaiwado, N; Cho, YM; Takahashi, S; Ikeda, Y; Imaida, K; Shirai, T
      Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent

      CANCER RESEARCH
    15. Laderoute, KR; Calaoagan, JM; Knapp, AM; Mendonca, HL; Johnson, RS
      c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Gillet, R; Cavard, C; Grimber, G; Briand, P; Joulin, V
      Hepatic expression of SV40 small-t antigen blocks the in vivo CD95-Mediated apoptosis

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Greenberg, NM
      Androgens and growth factors in prostate cancer: a transgenic perspective

      PROSTATE CANCER AND PROSTATIC DISEASES
    18. Snawder, JE; Savage, RE; Swaminathan, S; Frederickson, SM; Reznikoff, CA
      Characterization of cytochrome P450-dependent and glutathione transferase activities in SV40-immortalized uroepithelial cell lines: Possible role in transformation and tumor formation

      TOXICOLOGY METHODS
    19. Smith, LS; Tachibana, I; Lee, HK; Qian, JQ; Pohl, U; Mohrenweiser, HW; Borell, TJ; Hosek, SM; Soderberg, CL; von Deimling, A; Perry, A; Scheithauer, BW; Louis, DN; Jenkins, RB
      Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

      GENES CHROMOSOMES & CANCER
    20. McCormick, F
      Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015

      SEMINARS IN CANCER BIOLOGY
    21. Gao, JP; Uchida, T; Wang, CX; Jiang, SX; Matsumoto, K; Satoh, T; Minei, S; Soh, S; Kameya, T; Baba, S
      Relationship between p53 gene mutation and protein expression: Clinical significance in transitional cell carcinoma of the bladder

      INTERNATIONAL JOURNAL OF ONCOLOGY
    22. Varma, H; Conrad, SE
      Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain

      ONCOGENE
    23. Miyata, Y; Yahara, I
      p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90

      ONCOGENE
    24. Ichikawa, A
      Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    25. Bowman, KK; Sicard, DM; Ford, JM; Hanawalt, PC
      Reduced global genomic repair of ultraviolet light-induced cyclobutane pyrimidine dimers in simian virus 40-transformed human cells

      MOLECULAR CARCINOGENESIS
    26. Shin, MK
      Controlling gene expression in mice with tetracycline: Application in pigment cell research

      PIGMENT CELL RESEARCH
    27. Blagosklonny, MV
      p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect

      FASEB JOURNAL
    28. Fojta, M; Brazdova, M; Cernocka, H; Pecinka, P; Brazda, V; Palecek, J; Jagelska, E; Vojtesek, B; Pospisilova, S; Subramaniam, V; Jovin, TM; Palecek, E
      Effects of oxidation agents and metal ions on binding of p53 to supercoiled DNA

      JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
    29. Marin, MC; Kaelin, WG
      p63 and p73: Old members of a new family

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    30. Liu, Y; Colosimo, AL; Yang, XJ; Liao, DQ
      Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF

      MOLECULAR AND CELLULAR BIOLOGY
    31. Sullivan, CS; Tremblay, JD; Fewell, SW; Lewis, JA; Brodsky, JL; Pipas, JM
      Species-specific elements in the large T-antigen J domain are required forcellular transformation and DNA replication by simian virus 40

      MOLECULAR AND CELLULAR BIOLOGY
    32. Ghosh, SS; Takahashi, M; Thummala, NR; Parashar, B; Chowdhury, NR; Chowdhury, JR
      Liver-directed gene therapy: promises, problems and prospects at the turn of the century

      JOURNAL OF HEPATOLOGY
    33. Butel, JS
      Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease

      CARCINOGENESIS
    34. Oldstone, MBA; Levine, AJ
      Virology in the next millennium

      CELL
    35. Sheng, Q; Love, TM; Schaffhausen, B
      J domain-independent regulation of the Rb family by polyomavirus large T antigen

      JOURNAL OF VIROLOGY
    36. Strano, S; Munarriz, E; Rossi, M; Cristofanelli, B; Shaul, Y; Castagnoli, L; Levine, AJ; Sacchi, A; Cesareni, G; Oren, M; Blandino, G
      Physical and functional interaction between p53 mutants and different isoforms of p73

      JOURNAL OF BIOLOGICAL CHEMISTRY
    37. Zeimet, AG; Riha, K; Berger, J; Widschwendter, M; Hermann, M; Daxenbichler, G; Marth, C
      New insights into p53 regulation and gene therapy for cancer

      BIOCHEMICAL PHARMACOLOGY
    38. Oren, M; Rotter, V
      Introduction: p53 - the first twenty years

      CELLULAR AND MOLECULAR LIFE SCIENCES
    39. Hupp, TR
      Regulation of p53 protein function through alterations in protein-folding pathways

      CELLULAR AND MOLECULAR LIFE SCIENCES
    40. McCormick, F
      Cancer therapy based on p53

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    41. Bellas, RE; Sonenshein, GE
      Nuclear factor kappa B cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function

      CELL GROWTH & DIFFERENTIATION
    42. Komiya, T; Hirashima, T; Kawase, I
      Clinical significance of p53 in non-small cell lung cancer (Review)

      ONCOLOGY REPORTS
    43. Shimizu, T; Oga, A; Murakami, T; Muto, M
      Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis

      DERMATOLOGY
    44. Yap, DBS; Hsieh, JK; Chan, FSG; Lu, X
      mdm2: a bridge over the two tumour suppressors, p53 and Rb

      ONCOGENE
    45. Maroulakou, IG; Shibata, MA; Anver, M; Jorcyk, CL; Liu, ML; Roche, N; Roberts, AB; Tsarfaty, I; Reseau, J; Ward, J; Green, JE
      Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression

      ONCOGENE
    46. Kuhn, C; Muller, F; Melle, C; Nasheuer, HP; Janus, F; Deppert, W; Grosse, F
      Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha

      ONCOGENE
    47. Phillips, HA
      The role of the p53 tumour suppressor gene in human breast cancer

      CLINICAL ONCOLOGY
    48. Strayer, DS; Zern, MA
      Gene delivery to the liver using simian virus 40-derived vectors

      SEMINARS IN LIVER DISEASE
    49. Kappler, R; Pietsch, T; Weggen, S; Wiestler, OD; Scherthan, H
      Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat

      CARCINOGENESIS
    50. Nishikawa, T; Arai, S; Uobe, K; Wato, M; Tominaga, K; Masuno, K; Mori, M; Yoshida, S; Kobayashi, H; Tanaka, A
      A double staining method for histone H3 mRNA and p53 protein in oral tumors using in situ hybridization and immunohistochemistry

      ACTA HISTOCHEMICA ET CYTOCHEMICA
    51. Zimmermann, H; Degenkolbe, R; Bernard, HU; O'Connor, MJ
      The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300

      JOURNAL OF VIROLOGY
    52. Prives, C; Hall, PA
      The P53 pathway

      JOURNAL OF PATHOLOGY
    53. Strayer, DA
      Gene therapy using SV40-derived vectors: What does the future hold?

      JOURNAL OF CELLULAR PHYSIOLOGY
    54. Fang, L; Lee, SW; Aaronson, SA
      Comparative analysis of p73 and p53 regulation and effector functions

      JOURNAL OF CELL BIOLOGY
    55. Freedman, DA; Levine, AJ
      Regulation of the p53 protein by the MDM2 oncoprotein - Thirty-eighth G.H.A. Clowes Memorial Award lecture

      CANCER RESEARCH
    56. Kohli, M; Jorgensen, TJ
      The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    57. Kaelin, WG
      The emerging p53 gene family

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    58. Xie, YC; Hwang, C; Overwijk, W; Zeng, Z; Eng, MH; Mule, JJ; Imperiale, MJ; Restifo, NP; Sanda, MG
      Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    59. ROBERTS RA
      CURRENT ISSUES IN MUTAGENESIS AND CARCINOGENESIS, NO. 85 - TRANSGENICRODENT MUTATION CANCER BIOASSAYS - CELL-CYCLE CONTROL, CELL-PROLIFERATION AND APOPTOSIS AS MODIFIERS OF OUTCOME

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    60. VANRENSBURG EJ; ENGELBRECHT S; VANHEERDEN WFP; KOTZE MJ; RAUBENHEIMER EJ
      DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE

      Human mutation
    61. VANRENSBURG EJ; ENGELBRECHT S; VANHEERDEN WFP; KOTZE MJ; RAUBENHEIMER EJ
      DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE

      Human mutation
    62. Peller, S
      Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response

      SEMINARS IN CANCER BIOLOGY
    63. SANCHEZPERNAUTE A; TORRES A; INIESTA P; HERNANDO F; GOMEZ A; GONZALEZ O; DEJUAN C; PEREZAGUIRRE E; MAESTRO ML; LOPEZASENJO JA; BENITO M; BALIBREA JL
      PROGNOSTIC-SIGNIFICANCE OF P53 GENE-MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE LUNG

      Oncology Reports
    64. Cokgor, I; Friedman, AH; Friedman, HS
      Paediatric update - Gliomas

      EUROPEAN JOURNAL OF CANCER
    65. WADDELL S; JENKINS JR
      DEFINING THE MINIMAL REQUIREMENTS FOR PAPILLOMA VIRAL E6-MEDIATED INHIBITION OF HUMAN P53 ACTIVITY IN FISSION YEAST

      Oncogene
    66. FRAZIER ML; INAMDAR N; ALVULA S; WU E; KIM YH
      FEW POINT MUTATIONS IN ELONGATION FACTOR-1-GAMMA GENE IN GASTROINTESTINAL CARCINOMA

      Molecular carcinogenesis
    67. HOFFSCHIR F; DAYAGROSJEAN L; PETIT PX; NOCENTINI S; DUTRILLAUX B; SARASIN A; VUILLAUME M
      LOW CATALASE ACTIVITY IN XERODERMA-PIGMENTOSUM FIBROBLASTS AND SV40-TRANSFORMED HUMAN CELL-LINES IS DIRECTLY RELATED TO DECREASED INTRACELLULAR LEVELS OF THE COFACTOR, NADPH

      Free radical biology & medicine
    68. DESTANCHINA E; MCCURRACH ME; ZINDY F; SHIEH SY; FERBEYRE G; SAMUELSON AV; PRIVES C; ROUSSEL MF; SHERR CJ; LOWE SW
      E1A SIGNALING TO P53 INVOLVES THE P19(ARF) TUMOR-SUPPRESSOR

      Genes & development
    69. ZWACKA RM; DUNLOP MG
      GENE-THERAPY FOR COLON-CANCER

      Hematology/oncology clinics of North America
    70. TRUCKENMILLER ME; TORNATORE C; WRIGHT RD; DILLONCARTER O; MEINERS S; GELLER HM; FREED WJ
      A TRUNCATED SV40 LARGE T-ANTIGEN LACKING THE P53 BINDING DOMAIN OVERCOMES P53-INDUCED GROWTH ARREST AND IMMORTALIZES PRIMARY MESENCEPHALIC CELLS

      Cell and tissue research
    71. DILLONCARTER O; CONEJERO C; TORNATORE C; POLTORAK M; FREED WJ
      N18-RE-105 CELLS - DIFFERENTIATION AND ACTIVATION OF P53 IN RESPONSE TO GLUTAMATE AND ADRIAMYCIN IS BLOCKED BY SV40 LARGE T-ANTIGEN TSA58

      Cell and tissue research
    72. MARIN MC; JOST CA; IRWIN MS; DECAPRIO JA; CAPUT D; KAELIN WG
      VIRAL ONCOPROTEINS DISCRIMINATE BETWEEN P53 AND THE P53 HOMOLOG P73

      Molecular and cellular biology (Print)
    73. Reddel, RR
      A reassessment of the telomere hypothesis of senescence

      BIOESSAYS
    74. BROWN DR; THOMAS CA; DEB SP
      THE HUMAN ONCOPROTEIN MDM2 ARRESTS THE CELL-CYCLE - ELIMINATION OF ITS CELL-CYCLE-INHIBITORY FUNCTION INDUCES TUMORIGENESIS

      EMBO journal
    75. RUTZ HP; MARIOTTA M; DOEBERITZ MV; MIRIMANOFF RO
      DEXAMETHASONE-INDUCED RADIORESISTANCE OCCURRING INDEPENDENT OF HUMAN PAPILLOMA-VIRUS GENE-EXPRESSION IN CERVICAL-CARCINOMA CELLS

      Strahlentherapie und Onkologie
    76. NEWMASTER RS; MYLIN LM; FU TM; TEVETHIA SS
      ROLE OF A SUBDOMINANT H-2K(D)-RESTRICTED SV40 TUMOR-ANTIGEN CYTOTOXICT-LYMPHOCYTE EPITOPE IN TUMOR REJECTION

      Virology
    77. Higashino, F; Pipas, JM; Shenk, T
      Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    78. WU M; BELLAS RE; SHEN J; SONENSHEIN GE
      ROLES OF THE TUMOR-SUPPRESSOR P53 AND THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1 CTP1) IN RECEPTOR-MEDIATED APOPTOSIS OF WEHI-231 B-LYMPHOMA-CELLS/

      The Journal of experimental medicine
    79. Gallia, GL; Safak, M; Khalili, K
      Interaction of the single-stranded DNA-binding protein Pur alpha with the human polyomavirus JC virus early protein T-antigen

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. POWELL AJ; GATES PB; WYLIE D; VELLOSO CP; BROCKES JP; JAT PS
      IMMORTALIZATION OF RAT EMBRYO FIBROBLASTS BY A 3'-UNTRANSLATED REGION

      Experimental cell research
    81. STEELE RJC; THOMPSON AM; HALL PA; LANE DP
      THE P53 TUMOR-SUPPRESSOR GENE

      British Journal of Surgery
    82. Monier, R
      DNA tumor viruses: probes for the discovery of tumour suppressor genes

      EUROCANCER 98
    83. GALLIMORE PH; LECANE PS; HANN B; GRAND RJA
      DIFFERENTIATION IS INHIBITED AND A SENESCENCE PATHWAY IS ACTIVATED WHEN SIMIAN-VIRUS-40 TSA 58-TRANSFORMED HUMAN RETINOBLASTS ARE GROWN AT THE RESTRICTIVE TEMPERATURE

      Cell growth & differentiation
    84. KOENIG MG; STURM D; PROWALD A; ISSINGER OG; MONTENARH M
      INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE

      International journal of oncology
    85. LANE DP; HALL PA
      MDM2 - ARBITER OF P53S DESTRUCTION

      Trends in biochemical sciences
    86. TRUCKENMILLER ME; DILLONCARTER O; TORNATORE C; KULAGA H; TAKASHIMA H; FREED WJ
      GROWTH-PROPERTIES OF NEURAL CELL-LINES IMMORTALIZED WITH THE TSA58 ALLELE OF SV40 LARGE T-ANTIGEN

      Cell transplantation
    87. MONTANO X
      P53 ASSOCIATES WITH TRK TYROSINE KINASE

      Oncogene
    88. LINKE SP; HARRIS MP; NEUGEBAUER SE; CLARKIN KC; SHEPARD HM; MANEVAL DC; WAHL GM
      P53-MEDIATED ACCUMULATION OF HYPOPHOSPHORYLATED PRB AFTER THE G(1) RESTRICTION POINT FAILS TO HALT CELL-CYCLE PROGRESSION

      Oncogene
    89. BLAGOSKLONNY MV
      LOSS OF FUNCTION AND P53 PROTEIN STABILIZATION

      Oncogene
    90. MIDGLEY CA; LANE DP
      P53 PROTEIN STABILITY IN TUMOR-CELLS IS NOT DETERMINED BY MUTATION BUT IS DEPENDENT ON MDM2 BINDING

      Oncogene
    91. ONEILL FJ; HU Y; CHEN T; CARNEY H
      IDENTIFICATION OF P53 UNBOUND TO T-ANTIGEN IN HUMAN-CELLS TRANSFORMEDBY SIMIAN-VIRUS-40 T-ANTIGEN

      Oncogene
    92. STIEGLER P; SCHUCHNER S; LESTOU V; WINTERSBERGER E
      POLYOMAVIRUS LARGE-T-ANTIGEN-DEPENDENT DNA AMPLIFICATION

      Oncogene
    93. SIMONS A; MELAMEDBESSUDO C; WOLKOWICZ R; SPERLING J; SPERLING R; EISENBACH L; ROTTER V
      PACT - CLONING AND CHARACTERIZATION OF A CELLULAR P53 BINDING-PROTEINTHAT INTERACTS WITH RB

      Oncogene
    94. LOMAX ME; BARNES DM; GILCHRIST R; PICKSLEY SM; VARLEY JM; CAMPLEJOHN RS
      2 FUNCTIONAL ASSAYS EMPLOYED TO DETECT AN UNUSUAL MUTATION IN THE OLIGOMERIZATION DOMAIN OF P53 IN A LI-FRAUMENI LIKE FAMILY

      Oncogene
    95. MURAKAMI SI; UCHIDA Y; TAKENO SS; NOGUCHI T; MATSUMOTO K; SHIMODA H
      EXPRESSION OF PCNA AND P53 IN ESOPHAGEAL DYSPLASIA AND ESOPHAGEAL-CARCINOMA

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    96. SHVARTS A; BAZUINE M; DEKKER P; RAMOS YFM; STEEGENGA WT; MERCKX G; VANHAM RCA; VANOORDT WV; VANDEREB AJ; JOCHEMSEN AG
      ISOLATION AND IDENTIFICATION OF THE HUMAN HOMOLOG OF A NEW P53-BINDING PROTEIN, MDMX

      Genomics
    97. BROWN J; HIGO H; MCKALIP A; HERMAN B
      HUMAN PAPILLOMAVIRUS (HPV)-16-E6 SENSITIZES CELLS TO ATRACTYLOSIDE-INDUCED APOPTOSIS - ROLE OF P53, ICE-LIKE PROTEASES AND THE MITOCHONDRIAL PERMEABILITY TRANSITION

      Journal of cellular biochemistry
    98. WOLKOWICZ R; ROTTER V
      THE DNA-BINDING REGULATORY DOMAIN OF P53 - SEE THE C

      Pathologie et biologie
    99. MILNER J
      STRUCTURES AND FUNCTIONS OF THE TUMOR-SUPPRESSOR P53

      Pathologie et biologie
    100. PUISIEUX A; OZTURK M
      TP53 AND HEPATOCELLULAR-CARCINOMA

      Pathologie et biologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 18:26:14